Related Experiment Video

Updated: Aug 17, 2026

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
08:11

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique

Published on: November 11, 2022

Mechanisms by which K(ATP) channel openers produce acute and delayed cardioprotection

Yigang Wang1, Husnain Khawaja Haider, Nauman Ahmad

  • 1Department of Pathology and Laboratory Medicine, University of Cincinnati Medical Center, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267-0529, USA.

Vascular Pharmacology
|June 1, 2005
PubMed

Insights

Mitochondrial K(ATP) channels are key to cardioprotection, offering a promising drug target. Understanding their role in ischemic preconditioning is crucial for developing new cardiac therapies.

Area of Science:

  • Mitochondrial physiology
  • Cardiovascular research
  • Cellular signaling

Background:

  • Mitochondria play a vital role in cell survival.
  • Signaling pathways converge on K+-sensitive ATP channels for cytoprotection.
  • Potassium channel openers regulate cell excitability and electrolyte transfer.

Purpose of the Study:

  • To review recent advances in understanding the physiological role of K(ATP) channels in cardiac protection.
  • To highlight key questions and controversies regarding K(ATP) channels in ischemic preconditioning.
  • To explore K(ATP) channels as a potential drug target for myocardial protection.

Main Methods:

  • Literature review of published data on K(ATP) channels and cardiac protection.
  • Analysis of signaling pathways involving mitochondrial K(ATP) channels.
  • Examination of studies on potassium channel openers and their effects on the myocardium.

Main Results:

  • Cardiac mitoK(ATP) channels are critical effectors in cardioprotection during ischemic preconditioning.
  • These channels are hypothesized to link myocardial metabolism with electrical activity.
  • Several K(ATP) channel openers demonstrate beneficial effects against ischemic injury.

Conclusions:

  • Mitochondrial K(ATP) channels are central to the mechanism of ischemic preconditioning.
  • Further research is needed to elucidate the precise mechanisms and therapeutic potential.
  • K(ATP) channels represent a significant therapeutic target for treating cardiac ischemic injury.

More Related Videos

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion13:42

A Murine Closed-chest Model of Myocardial Ischemia and Reperfusion

Published on: July 17, 2012

Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time08:33

Measuring Nucleotide Binding to Intact, Functional Membrane Proteins in Real Time

Published on: March 11, 2021

Related Concept Videos

G-Protein Gated Ion Channels01:21

G-Protein Gated Ion Channels

GPCRs are primarily responsible for our sense of smell, taste, and vision.  The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory organs,...
Primary Active Transport01:29

Primary Active Transport

In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction they would not...
Primary Active Transport01:47

Primary Active Transport

In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps that are embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction they...
Cardiac Action Potential01:30

Cardiac Action Potential

Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Active Transport01:14

Active Transport

Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...